TLDR

MARKET RECAP → Stocks climbed Thursday as upbeat earnings from two Big Tech giants calmed fears that economic turbulence might stall AI momentum.

MCDONALD’S HIT BY U.S. SALES SLUMP → 🍔 McDonald’s posted its biggest U.S. same-store sales drop since 2020 as cautious consumers pulled back, but still managed to beat earnings expectations with global markets providing some offset.

LILLY OFFERS HELP ON DRUG SECURITY → 💊 Eli Lilly said it’s ready to help the U.S. reduce its dependence on foreign-made generic drugs, but its CEO isn’t convinced tariffs are the right prescription.

Was this email forwarded to you? Sign up for free here.

Earn rewards by referring friends. Scroll to the bottom to learn more! 👇️ 

MARKETS

Market Snapshot

Today’s S&P 500 Heatmap

Notable Earnings This Week

TODAY’S TOP NEWS

McDonald’s Hit By U.S. Sales Slump

🍟 U.S. same-store sales dropped 3.6% in Q1, the chain’s steepest domestic decline since 2020, driven by bad weather and hesitant low- and middle-income consumers. It marked the second consecutive quarter of shrinking U.S. traffic.

📉 Global same-store sales fell 1%, missing analyst expectations, while total revenue slid 3% to $5.96 billion. Still, McDonald’s narrowly beat earnings estimates with $2.67 per share (adjusted).

🌍 International licensed markets like China and Brazil saw 3.5% growth, helping balance losses elsewhere. The company reaffirmed plans to open 2,200 stores and lean on value menus to attract cost-conscious diners.

TODAY’S TOP NEWS

Lilly Offers Help On Drug Security

💊 Eli Lilly CEO Dave Ricks said the company could aid national security by reshoring production of essential older drugs, as the Trump administration investigates pharmaceutical imports with tariffs looming.

📦 Ricks acknowledged the risks tied to offshore generic drug production, noting that while tariffs may not be the best solution, the mere threat is already sparking domestic investment.

🏭 Eli Lilly pledged $27 billion for new U.S. production sites and advocated for a 15% corporate tax rate to bring more pharma manufacturing back to American soil.

KEEP READING

Amazon beats on top and bottom line but issues light second quarter guidance (CNBC)

Mercedes-Benz to add new vehicle to Alabama plant amid Trump tariffs (CNBC)

Sam Altman’s eye-scanning ID project launches in U.S. with six locations (CNBC)

GM lowers 2025 guidance, citing up to $5 billion in tariff exposure (CNBC)

CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans (CNBC)

How to Prepare Your Budget for Tariff Surcharges (ML)

Why You’ll Love the Money Master Challenge – Your Daily Finance Game! (ML)

BULL VS. BEAR

NOTABLE POSTS

MONEYLION MANAGED INVESTING

A MESSAGE FROM OUR PARTNER

WHAT WE’RE WATCHING

OUR FAVORITE TOOLS & RESOURCES

• Polymarket — The world’s largest prediction market

• Unusual Whales — Companion for uncovering unusual market activity

• OpenBB — AI-powered research and analytics workspace

• Earnings Hub — Earnings calendar

• Quiver Quantitative — Quiver allows retail investors to tap into the power of big data with insights into things like congressional trades as they are disclosed

• Perplexity — Perplexity AI is an AI-chatbot-powered research and conversational search engine

• The Market Ear — Live news, analysis and commentary on what moves markets and trading

• Coinmarketcap.com — Crypto market data

• Finviz — Financial visualizations

• Trading Economics — Economic calendar

• CME FedWatch Tool — Market-implied probabilities of future levels of interest rates 

• Dataroma — Track stock picks and portfolios of legendary value investors such as Warren Buffett

• ChatGPT — Large language model-based chatbot powered by generative AI

• Vimcal — Lightning-fast calendar and AI scheduling assistant

REFERRAL PROGRAM

WE WANT YOUR FEEDBACK

^{_{Investment advisory services provided by ML Wealth LLC. Investment Accounts Are Not FDIC Insured • No Bank Guarantee • Investments May Lose Value. For important information and disclosures relating to the MoneyLion Investment Account, see Investment FAQs, Form ADV Brochure, and moneylion.com/investing. Funded managed investing accounts are subject to a monthly account fee of $1 (for accounts valued up to $5,000), $3 (for accounts valued over $5,000, and up to $25,000), or $5 (for accounts valued over $25,000).}}

<sup><sub>This advertising email was sent to you because you have a MoneyLion account. If you would like to unsubscribe, please do so using this link. We respect your right to privacy. Please do not reply to this email with sensitive information, such as an account number, Social Security number, date of birth, bank account information, PIN, password, or Online ID. The security and confidentiality of your personal information is important to us. If you have any questions or want to read more, please visit our Help Center.

MoneyLion and Pathward do not provide, nor do they guarantee, any third-party product, service, information, or recommendation. The third parties providing these products or services are solely responsible for them, as well as all other content on their websites. MoneyLion is not liable for any third party’s failure with regard to those advertised products, services, and benefits. These advertised products and services may not be FDIC insured or bank-guaranteed, and may be subject to a different privacy policy than MoneyLion’s. You should check individual offers, products, and services to become familiar with any applicable restrictions or conditions that may apply. MoneyLion may receive compensation from third parties for referring you to the third party, their products or to their website.

The influencer, creator and other content provided in the MoneyLion App (“Content”) is for informational and entertainment purposes only and should not be construed as legal, tax, investment, financial, or other advice. All Content is intended to be of a general nature, does not address the circumstances of any particular individual or entity, and may not constitute a comprehensive or complete statement of the matters discussed. MoneyLion is not a fiduciary by virtue of any person’s use of or reliance on the Content. You should consult an appropriate professional if you require any legal, tax, investment, financial or other advice. Terms and Conditions for our subscriber referral can be found here.</sub></sup>